GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » Total Stockholders Equity

Sensus Healthcare (Sensus Healthcare) Total Stockholders Equity : $48.84 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare Total Stockholders Equity?

Sensus Healthcare's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $48.84 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sensus Healthcare's Book Value per Share for the quarter that ended in Dec. 2023 was $2.98. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sensus Healthcare's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.02.

Sensus Healthcare Total Stockholders Equity Historical Data

The historical data trend for Sensus Healthcare's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensus Healthcare Total Stockholders Equity Chart

Sensus Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.00 21.50 26.02 48.07 48.84

Sensus Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.07 46.32 46.01 44.59 48.84

Sensus Healthcare  (NAS:SRTS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sensus Healthcare's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(48.842-0)/16.3742
=2.98

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sensus Healthcare's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.187 + 0.596) / 48.842
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sensus Healthcare Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensus Healthcare (Sensus Healthcare) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » Total Stockholders Equity
Comparable Companies
ECOR ICCM ICAD RPID CODX RWLK BSGM PAVM MYO UTRS ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
5TX:Germany
Address
851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Website
https://www.sensushealthcare.com
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Executives
Joseph C Sardano director, officer: Chief Executive Officer 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Michael Sardano officer: GENERAL COUNSEL 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
John Heinrich director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Samuel O'rear director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall director 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Javier Rampolla officer: Chief Financial Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish director 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman officer: CHIEF TECHNOLOGY OFFICER 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487